116 related articles for article (PubMed ID: 3827423)
21. Role of HLA-DR antigens in Japanese patients with sarcoidosis.
Kunikane H; Abe S; Tsuneta Y; Nakayama T; Tajima Y; Misonou J; Wakisaka A; Aizawa M; Kawakami Y
Am Rev Respir Dis; 1987 Mar; 135(3):688-91. PubMed ID: 3826893
[TBL] [Abstract][Full Text] [Related]
22. [Association of HLA with sarcoidosis].
Wang HD
Zhonghua Jie He He Hu Xi Za Zhi; 1989 Aug; 12(4):200-3, 253. PubMed ID: 2636943
[TBL] [Abstract][Full Text] [Related]
23. HLA class II genotyping of sarcoidosis patients in Hokkaido by PCR-RFLP.
Ishihara M; Inoko H; Suzuki K; Ono H; Hiraga Y; Ando H; Naruse T; Ishida T; Ohno S
Jpn J Ophthalmol; 1996; 40(4):540-3. PubMed ID: 9130059
[TBL] [Abstract][Full Text] [Related]
24. [Comparison of HLA class I and DR class II antigen frequency in Polish patients, in relation to different stages of the disease].
Puścińska E; Goljan A; Zych D; Pawlicka L; Kowalski J; Zieliński J
Pneumonol Alergol Pol; 2000; 68(11-12):498-509. PubMed ID: 11320561
[TBL] [Abstract][Full Text] [Related]
25. Adverse effect of chronic tonsillitis on clinical course of sarcoidosis in relation to HLA distribution.
Ikeda T; Hayashi S; Kamikawaji N; Sasazuki T; Shigematsu N
Chest; 1992 Mar; 101(3):758-62. PubMed ID: 1541144
[TBL] [Abstract][Full Text] [Related]
26. HLA associations in sarcoidosis: a study of two ethnic groups.
Gardner J; Kennedy HG; Hamblin A; Jones E
Thorax; 1984 Jan; 39(1):19-22. PubMed ID: 6582657
[TBL] [Abstract][Full Text] [Related]
27. HLA-DR antigens on human macrophages from bronchoalveolar lavage fluid.
Costabel U; Bross KJ; Andreesen R; Matthys H
Thorax; 1986 Apr; 41(4):261-5. PubMed ID: 3461577
[TBL] [Abstract][Full Text] [Related]
28. Association of HLA B8 with spontaneous resolution in sarcoidosis.
Smith MJ; Turton CW; Mitchell DN; Turner-Warwick M; Morris LM; Lawler SD
Thorax; 1981 Apr; 36(4):296-8. PubMed ID: 7281099
[TBL] [Abstract][Full Text] [Related]
29. HLA in a cohort of Brazilian patients with sarcoidosis.
da Costa CH; Silva VL; Fabricio-Silva GM; Usnayo M; Rufino R; Porto LC
Hum Immunol; 2013 Oct; 74(10):1326-32. PubMed ID: 23911360
[TBL] [Abstract][Full Text] [Related]
30. Analysis of restriction fragment length polymorphism for the HLA-DR gene in Japanese patients with sarcoidosis.
Kunikane H; Abe S; Yamaguchi E; Aparicio JM; Wakisaka A; Yoshiki T; Kawakami Y
Thorax; 1994 Jun; 49(6):573-6. PubMed ID: 7912453
[TBL] [Abstract][Full Text] [Related]
31. Expression of HLA class II genes in alveolar macrophages of patients with sarcoidosis.
Spurzem JR; Saltini C; Kirby M; Konishi K; Crystal RG
Am Rev Respir Dis; 1989 Jul; 140(1):89-94. PubMed ID: 2526608
[TBL] [Abstract][Full Text] [Related]
32. HLA class II amino acid epitopes as susceptibility markers of sarcoidosis.
Voorter CE; Amicosante M; Berretta F; Groeneveld L; Drent M; van den Berg-Loonen EM
Tissue Antigens; 2007 Jul; 70(1):18-27. PubMed ID: 17559577
[TBL] [Abstract][Full Text] [Related]
33. HLA-Gm/kappam interaction in sarcoidosis. Suggestions for a complex genetic structure.
Martinetti M; Dugoujon JM; Tinelli C; Cipriani A; Cortelazzo A; Salvaneschi L; Casali L; Semenzato G; Cuccia M; Luisetti M
Eur Respir J; 2000 Jul; 16(1):74-80. PubMed ID: 10933088
[TBL] [Abstract][Full Text] [Related]
34. HLA and sarcoidosis.
Mehra NK; Bovornkitti S
Sarcoidosis; 1988 Sep; 5(2):87-9. PubMed ID: 3227192
[TBL] [Abstract][Full Text] [Related]
35. Genetic influences on sarcoidosis.
Ishihara M; Ohno S
Eye (Lond); 1997; 11 ( Pt 2)():155-61. PubMed ID: 9349405
[TBL] [Abstract][Full Text] [Related]
36. [The effect of genetically determined factors on the development and course of sarcoidosis].
Dushimbekova KA; Romanov VV; Pospelov LE
Probl Tuberk; 1993; (1):27-9. PubMed ID: 8327433
[TBL] [Abstract][Full Text] [Related]
37. Sarcoidosis and tuberculosis: a connection to the human leukocyte antigen system.
Dubaniewicz A; Zimmermann A; Smigielska M; Dubaniewicz-Wybieralska M; Moszkowska G; Wysocka J; Adamczyk-Bak K; Slominski JM; Deeg P
Adv Exp Med Biol; 2013; 756():229-37. PubMed ID: 22836640
[TBL] [Abstract][Full Text] [Related]
38. "The sarcoidosis map": a joint survey of clinical and immunogenetic findings in two European countries.
Martinetti M; Tinelli C; Kolek V; Cuccia M; Salvaneschi L; Pasturenzi L; Semenzato G; Cipriani A; Bartova A; Luisetti M
Am J Respir Crit Care Med; 1995 Aug; 152(2):557-64. PubMed ID: 7633707
[TBL] [Abstract][Full Text] [Related]
39. HLA class II (DR, DQ, DP) in patients with sarcoidosis: evidence of an increased frequency of DRw6.
Odum N; Milman N; Jakobsen BK; Georgsen J; Svejgaard A
Exp Clin Immunogenet; 1991; 8(4):227-32. PubMed ID: 1817566
[TBL] [Abstract][Full Text] [Related]
40. Clinical course of sarcoidosis in dependence on HLA-DRB1 allele frequencies, inflammatory markers, and the presence of M. tuberculosis DNA fragments.
Grosser M; Luther T; Fuessel M; Bickhardt J; Magdolen V; Baretton G
Sarcoidosis Vasc Diffuse Lung Dis; 2005 Mar; 22(1):66-74. PubMed ID: 15881283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
